Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. scores highest on Torque (68) and lowest on Price (33). Its PosiPenta is 50.89 out of 100, around the middle of similar companies.
On the Penta Grid this week, Inhibikase Therapeutics, Inc. is Grid #272 of 837 in the Healthcare sector in United States, and Grid #1,775 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | 50.89 | 33 | 44 | 59 | 68 | 51 |
| Greenwich LifeSciences, Inc. | 38.62 | 1 | 47 | 46 | 45 | 54 |
| BridgeBio Oncology Therapeutics, Inc. | 41.90 | 43 | 37 | 11 | 55 | 63 |
| SIGA Technologies, Inc. | 58.32 | 34 | 87 | 32 | 78 | 60 |
| TriSalus Life Sciences, Inc. | 35.27 | 1 | 57 | 47 | 4 | 66 |
| Lyell Immunopharma, Inc. | 34.94 | 41 | 32 | 20 | 37 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.84 |
| P/B ratio | 1.50 |
EEarnings
| Trailing EPS | ₹-40.73 |
| Forward EPS | ₹-39.78 |
NNitro
| Price | 156.28 |
| 52-week high | 247.21 |
| 52-week low | 125.97 |
| Fall from 52-week high | 36.8% |
TTorque
| Return on equity (ROE) | -51.96% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.90 |
| Market cap | ₹2,180 Cr |
| Insider holding | 6.09% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Inhibikase Therapeutics, Inc.'s PosiPenta score?
Inhibikase Therapeutics, Inc.'s PosiPenta is 50.89 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Inhibikase Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Inhibikase Therapeutics, Inc. is Grid #272 of 837 in the Healthcare sector in United States, and Grid #1,775 of 4,000 in United States.
Which PosiPenta pillar is strongest for Inhibikase Therapeutics, Inc.?
Torque (durability), with a score of 68 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Inhibikase Therapeutics, Inc.?
Price (valuation), with a score of 33 out of 100: weaker than most similar companies.
Has Inhibikase Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.43 points, from 49.46 to 50.89.
PositoAI is for research and education only and is not investment advice.